CLX earnings

OAKLAND, Calif., April 30, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2026, which ended March 31, 2026.Third-Quarter Fiscal Year 2026 SummaryFollowing is a summary of key results for the third quarter. All comparisons are with the third quarter of fiscal year 2025 unless otherwise stated.Net sales of $1.67 billion were flat versus the year-ago quarter. Organic sales1 decreased 1%.Gross margin decreased 140 basis points to 43.2% from 44.6% in the year-ago quarter, primarily driven by higher manufacturing and logistics costs and unfavorable mix, partially offset by cost savings.Diluted net earnings per share (diluted EPS) incr

OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2026, which ended December 31, 2025. Second-Quarter Fiscal Year 2026 Summary Following is a summary of key results for the second quarter. All comparisons are with the second quarter of fiscal year 2025 unless otherwise stated. Net sales decreased 1% to $1.67 billion, primarily driven by lower consumption and partially offset by shipments ahead of consumption for several businesses. Organic sales1 decreased 1%.Gross margin decreased 60 basis points to 43.2% from 43.8% in the year-ago quarter, primarily driven by higher manufacturing and logistics costs, par

Expands Clorox's position in health and hygiene to include skin hygiene Clorox's scale, innovation and distribution capabilities poised to accelerate consumer growth for the Purell brand while GOJO's B2B reach and capabilities bolster Clorox's professional business Acquisition is growth accretive and advances IGNITE strategy; further evolving Clorox's portfolio to strengthen its ability to deliver more consistent, profitable growth OAKLAND, Calif., Jan. 22, 2026  The Clorox Company (NYSE:CLX) today announced that it has entered into a definitive agreement to acquire GOJO Indu

Reports sales and earnings decline primarily due to expected impact of ERP transition OAKLAND, Calif., Nov. 3, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the first quarter of fiscal year 2026, which ended September 30, 2025. First-Quarter Fiscal Year 2026 Summary Following is a summary of key results for the first quarter, which reflects the impact from incremental shipments associated with the enterprise resource planning transition in the U.S. (incremental ERP shipments) in the prior fiscal year and the prior divestiture of the Better Health Vitamins, Minerals and Supplements (VMS) business. All comparisons are with the first quarter of fiscal year 2025 u

Delivers strong margin expansion and adjusted EPS growth for FY25 despite challenging environment in the second half of the fiscal year OAKLAND, Calif., July 31, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the fourth quarter and fiscal year 2025, which ended June 30, 2025. Fourth-Quarter Fiscal Year 2025 Summary The following is a summary of key fourth-quarter results, which reflect the temporary benefit from incremental shipments related to building retailer inventory in advance of the enterprise resource planning transition in the U.S. (incremental ERP shipments) and the impact from the prior divestiture of the Better Health Vitamins, Minerals and Supplem

Delivers lower-than-expected sales amid a challenging and volatile consumer and geopolitical environment while maintaining overall market shares and delivering its 10th consecutive quarter of gross margin expansion OAKLAND, Calif., May 5, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2025, which ended Mar. 31, 2025. Third-Quarter Fiscal Year 2025 Summary Following is a summary of key results for the third quarter, which reflect the prior divestitures of the Better Health Vitamins, Minerals and Supplements (VMS) and Argentina businesses. All comparisons are with the third quarter of fiscal year 2024 unless otherwise stated. Net

OAKLAND, Calif., Feb. 3, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2025, which ended Dec. 31, 2024. Alongside these results, the company also announced that Clorox and P&G have jointly decided to wind down the Glad® bags and wraps joint venture as of Jan. 31, 2026, and the company intends to acquire P&G's 20% interest in the venture at its termination.   Second-Quarter Fiscal Year 2025 Summary Following is a summary of key results for the second quarter, which reflect the lapping of the operational recovery following the August 2023 cyberattack. Results also reflect the prior divestitures of the Better Health Vitamins, Min

OAKLAND, Calif., Oct. 30, 2024 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the first quarter of fiscal year 2025, which ended Sep. 30, 2024. First-Quarter Fiscal Year 2025 Summary Following is a summary of key results for the first quarter, which reflect the lapping of the impacts of the August 2023 cyberattack and include the company's Better Health Vitamins, Minerals and Supplements (VMS) business through its sale date of Sept. 10, 2024. Results also reflect the prior divestiture of the Argentina business. All comparisons are with the first quarter of fiscal year 2024 unless otherwise stated. Net sales increased 27% to $1.76 billion compared to a 20% net sales

Company Announces Sale of its Better Health Vitamins, Minerals and Supplements Business OAKLAND, Calif., Aug. 1, 2024 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the fourth quarter and fiscal year 2024, which ended June 30, 2024. Alongside these results, the company also announced it has entered into a definitive agreement to divest its Better Health Vitamins, Minerals and Supplements (VMS) business in its entirety to Piping Rock Health Products, LLC. Fourth-Quarter Fiscal Year 2024 Summary The following is a summary of key fourth-quarter results. All comparisons are with the fourth quarter of fiscal year 2023 unless otherwise stated. Net sales decreased 6% to $1

OAKLAND, Calif., Apr. 30, 2024 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2024, which ended Mar. 31, 2024. Third-Quarter Fiscal Year 2024 Summary Following is a summary of key results for the third quarter, which reflect continued operational recovery from the previously announced cyberattack. Third-quarter results reflect the March 20, 2024 divestiture of the company's Argentina business and all comparisons are with the third quarter of fiscal year 2023 unless otherwise stated. Net sales decreased 5% to $1.81 billion compared to a 6% net sales increase in the year-ago quarter. The decrease was driven largely by lower volume from

OAKLAND, Calif., Feb. 1, 2024 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2024, which ended Dec. 31, 2023. Second-Quarter Fiscal Year 2024 Summary Following is a summary of key results for the second quarter, which reflect operational recovery from the previously announced cyberattack. All comparisons are with the second quarter of fiscal year 2023 unless otherwise stated. Net sales increased 16% to $1.99 billion compared to a 1% net sales increase in the year-ago quarter. The increase was driven largely by higher volume as the company rebuilt customer inventories following the August cyberattack as well as favorable price mix, p

OAKLAND, Calif., Aug. 2, 2023 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the fourth quarter and fiscal year 2023, which ended June 30, 2023. Fourth-Quarter Fiscal Year 2023 Summary Following is a summary of key fourth-quarter results. All comparisons are with the fourth quarter of fiscal year 2022 unless otherwise stated. Net sales increased 12% to $2.0 billion compared to flat sales in the year-ago quarter. The net sales increase was driven largely by favorable price mix, partially offset by lower volume and unfavorable foreign exchange rates. Organic sales1 were up 14%.Gross margin increased 560 basis points to 42.7% from 37.1% in the year-ago quarter due to t

OAKLAND, Calif., May 2, 2023 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2023, which ended March 31, 2023. Third-Quarter Fiscal Year 2023 Summary Following is a summary of key third-quarter results. All comparisons are with the third quarter of fiscal year 2022 unless otherwise stated. Net sales increased 6% to $1.91 billion compared to a 2% net sales increase in the year-ago quarter. The net sales increase was driven largely by favorable price mix, partially offset by lower volume. Organic sales1 were up 8%.Gross margin increased 590 basis points to 41.8% from 35.9% in the year-ago quarter, due to the benefits of pricing and cost

OAKLAND, Calif., Feb. 2, 2023 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2023, which ended Dec. 31, 2022. Second-Quarter Fiscal Year 2023 Summary Following is a summary of key second-quarter results. All comparisons are with the second quarter of fiscal year 2022 unless otherwise stated. Net sales increased 1% to $1.72 billion compared to an 8% net sales decrease in the year-ago quarter. The net sales increase was driven largely by favorable price mix, partially offset by lower volume. Organic sales1 were up 4%. The three-year average growth rate for net sales was 7%.Gross margin increased 320 basis points to 36.2% from 33% in t

OAKLAND, Calif., Nov. 1, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the first quarter of fiscal year 2023, which ended Sept. 30, 2022. First-Quarter Fiscal Year 2023 SummaryFollowing is a summary of key first-quarter results. All comparisons are with the first quarter of fiscal year 2022 unless otherwise stated. Net sales decreased 4% to $1.74 billion compared to a 6% net sales decrease in the year-ago quarter. The net sales decrease was driven largely by lower volume, partially offset by favorable price mix. Organic sales1 were down 2%. The three-year average growth rate for net sales was up 5%.Gross margin decreased 110 basis points to 36% from 37.1% in t

OAKLAND, Calif., Aug. 3, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the fourth quarter and fiscal year 2022, which ended June 30, 2022. Fourth-Quarter Fiscal Year 2022 Summary The following is a summary of key fourth-quarter results. All comparisons are with the fourth quarter of fiscal year 2021 unless otherwise stated. Net sales of $1.8 billion were flat versus the year-ago quarter, as lower shipments were offset by the benefit of pricing. Organic sales1 were up 1%. The three-year average growth rate for net sales was 3%.Gross margin of 37.1% was flat versus the year-ago quarter, due mainly to ongoing elevated commodity costs and manufacturing and logisti

OAKLAND, Calif., May 2, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2022, which ended March 31, 2022. Third-Quarter Fiscal Year 2022 Summary Following is a summary of key third-quarter results. All comparisons are with the third quarter of fiscal year 2021 unless otherwise stated. Net sales increased 2% to $1.8 billion compared to flat sales in the year-ago quarter. Net sales growth reflects higher shipments across all reportable segments. Organic sales1 also grew 2%. The three-year average growth rate for net sales was up 5%.Gross margin decreased 760 basis points to 35.9% from 43.5% in the year-ago quarter, due mainly to hi

OAKLAND, Calif., Feb. 3, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2022, which ended on Dec. 31, 2021. Second-Quarter Fiscal Year 2022 Summary Following is a summary of key second-quarter results. All comparisons are with the second quarter of fiscal year 2021 unless otherwise stated. Net sales declined 8% to $1.7 billion in comparison to a 27% increase in the year-ago quarter, or an increase of 19% on a two-year stack basis. The decline in net sales reflects a 10-point decline in volume and 2 points of favorable price mix. Foreign exchange was flat, and organic sales1 for the quarter declined 8%. Gross margin decreased 1

OAKLAND, Calif., Nov. 1, 2021 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the first quarter of fiscal year 2022, which ended on Sept. 30, 2021. First-Quarter Fiscal 2022 Summary Following is a summary of key first-quarter results. All comparisons are with the first quarter of fiscal year 2021 unless otherwise stated. Net sales declined 6% to $1.8 billion in comparison to a 27% increase in the year-ago quarter, or an increase of 21% on a two-year stack basis. The decline in net sales reflects a 2-point decline in volume, 3 points of unfavorable price mix and 1 point of unfavorable foreign exchange. Organic sales1 for the quarter declined 5%. Gross margin decrease

OAKLAND, Calif., Sept. 29, 2021 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today it will issue its first-quarter fiscal year 2022 results on Monday, Nov. 1, 2021, as follows: 1:15 p.m. PT/4:15 p.m. ET: Press release and prepared management remarks (in transcript and pre-recorded audio formats) will be posted on the company's website. 2:30 p.m. PT/5:30 p.m. ET: Live Q&A audio webcast for analysts with CEO Linda Rendle and Chief Financial Officer Kevin Jacobsen to address the company's results as shared in its press release and pre-recorded management remarks.A link to the live webcast, as well as archived versions of the webcast, press release and prepared remarks can be found a